Open access
Open access
Powered by Google Translator Translator

Allergy & Immunology

Review | Plasma exchange in the intensive care unit.

15 Aug, 2022 | 12:19h | UTC

Plasma exchange in the intensive care unit: a narrative review – Intensive Care Medicine

 

Commentary on Twitter

 

M-A | Interventions to reduce infections in patients with hematological malignancies.

15 Aug, 2022 | 11:51h | UTC

Interventions to reduce infections in patients with hematological malignancies: a systematic review and meta-analysis – Blood Advances

Commentary: Prophylactic Immunoglobulin, Vaccinations May Reduce Infections in Hematologic Malignancies – AJMC

 

Consensus Statement | Pharmacological management of allergic rhinitis.

11 Aug, 2022 | 12:10h | UTC

Pharmacological Management of Allergic Rhinitis: A Consensus Statement from the Malaysian Society of Allergy and Immunology – Journal of Asthma and Allergy

Related:

Pharmacologic Treatment of Seasonal Allergic Rhinitis: Synopsis of Guidance From the 2017 Joint Task Force on Practice Parameters – Annals of Internal Medicine

Chinese Society of Allergy Guidelines for Diagnosis and Treatment of Allergic Rhinitis – Allergy Asthma & Immunology Research

 

Guideline | Management of immunoglobulin replacement therapy.

5 Aug, 2022 | 14:35h | UTC

British Society for Immunology & United Kingdom Primary Immunodeficiency Network (UKPIN) consensus guideline for the management of immunoglobulin replacement therapy – Clinical and Experimental Immunology

 

M-A | Treating eosinophilic esophagitis with budesonide.

27 Jul, 2022 | 12:06h | UTC

A meta-analysis on randomized controlled trials of treating eosinophilic esophagitis with budesonide – Annals of Medicine

 

RCT | Efficacy and safety of Abrocitinib vs. Dupilumab in adults with moderate-to-severe atopic dermatitis.

25 Jul, 2022 | 12:44h | UTC

Efficacy and safety of abrocitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis: a randomised, double-blind, multicentre phase 3 trial – The Lancet (link to abstract – $ for full-text)

Related: Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis – New England Journal of Medicine

 

Systematic Review | Anti‐IL‐5 therapies for asthma.

14 Jul, 2022 | 12:40h | UTC

Anti‐IL‐5 therapies for asthma – Cochrane Library

Summary: Mepolizumab, reslizumab or benralizumab for people already taking inhaled steroids and long-acting beta 2-agonists for their asthma – Cochrane Library

 

M-A | Prenatal antibiotic exposure, asthma, and the atopic march.

8 Jul, 2022 | 11:31h | UTC

Prenatal antibiotic exposure, asthma, and the atopic march: A systematic review and meta-analysis – Allergy

 

Review | Cough hypersensitivity and chronic cough.

4 Jul, 2022 | 12:59h | UTC

Cough hypersensitivity and chronic cough – Nature Reviews Disease Primers (if the link is paywalled, try this one)

See also: Infographic (if the link is paywalled, try this one)

 

Commentary on Twitter

Bad news for Paxlovid? Coronavirus can find multiple ways to evade COVID-19 drug.

4 Jul, 2022 | 12:57h | UTC

Bad news for Paxlovid? Coronavirus can find multiple ways to evade COVID-19 drug – Science

See also: SARS-CoV-2 can evade Paxlovid by multiple mechanisms – News Medical

Opinion | FDA: Don’t rush a move to change the Covid-19 vaccine composition.

4 Jul, 2022 | 12:53h | UTC

FDA: Don’t rush a move to change the Covid-19 vaccine composition – STAT

Antibodies to combat viral infections: development strategies and progress.

4 Jul, 2022 | 12:51h | UTC

Antibodies to combat viral infections: development strategies and progress – Nature Reviews Drug Discovery (if the link is paywalled, try this one in PMC)

Consensus for the definition, classification, diagnosis, and management of urticaria.

1 Jul, 2022 | 11:32h | UTC

Taiwanese dermatological association consensus for the definition, classification, diagnosis, and management of urticaria: A 2021 update – Journal of the Formosan Medical Association

 

Survey: The multidimensional burden of atopic dermatitis among adults.

30 Jun, 2022 | 10:57h | UTC

The Multidimensional Burden of Atopic Dermatitis Among Adults: Results From a Large National Survey – JAMA Dermatology

 

RCT: A 2-week interruption in methotrexate treatment doubles the antibody response to a COVID-19 booster vaccine.

29 Jun, 2022 | 12:10h | UTC

Effect of a 2-week interruption in methotrexate treatment versus continued treatment on COVID-19 booster vaccine immunity in adults with inflammatory conditions (VROOM study): a randomised, open label, superiority trial – The Lancet Respiratory Medicine

News Releases:

Interrupting the treatment of vulnerable people on immune-suppressing medicines, doubles their antibody response to COVID-19 booster vaccination – University of Nottingham

Interrupting immune-suppressing treatment can boost COVID vaccine response – Imperial College London

Commentaries:

Improving COVID-19 vaccine immunogenicity by interrupting methotrexate treatment – The Lancet Respiratory Medicine

Covid-19: Pausing immune suppressing drugs enhances antibody response to boosters, study shows – The BMJ

Related Study: Two-week methotrexate discontinuation in patients with rheumatoid arthritis vaccinated with inactivated SARS-CoV-2 vaccine: a randomised clinical trial – Annals of Rheumatic Diseases

 

Commentary on Twitter

 

Guideline for the emergency management of anaphylaxis.

28 Jun, 2022 | 10:59h | UTC

A Clinical Practice Guideline for the Emergency Management of Anaphylaxis – Frontiers in Pharmacology

Related:

Wilderness Medical Society Clinical Practice Guidelines on Anaphylaxis – Wilderness and Environmental Medicine

Guideline (S2k) on acute therapy and management of anaphylaxis: 2021 update – Allergo Journal International

EAACI guidelines: Anaphylaxis (2021 update) – European Journal of Allergy and Immunology

 

Review: Management of moderate-severe atopic dermatitis in pediatric age.

27 Jun, 2022 | 11:32h | UTC

Narrative review on the management of moderate-severe atopic dermatitis in pediatric age of the Italian Society of Pediatric Allergology and Immunology (SIAIP), of the Italian Society of Pediatric Dermatology (SIDerP) and of the Italian Society of Pediatrics (SIP) – Italian Journal of Pediatrics

 

Analysis of 7 RCTs: Dupilumab treatment reduces hospitalizations in adults with moderate-to-severe atopic dermatitis.

27 Jun, 2022 | 10:56h | UTC

Dupilumab Treatment Reduces Hospitalizations in Adults With Moderate-to-Severe Atopic Dermatitis – The Journal of Allergy and Clinical Immunology: In Practice

Commentary: Treatment Reduces, Exterminates Hospitalizations in Adults With Moderate to Severe AD – Consultant360

 

Commentary on Twitter

 

EULAR/ACR points to consider for diagnosis, management and monitoring of the interleukin-1 mediated autoinflammatory diseases.

24 Jun, 2022 | 11:23h | UTC

The 2021 EULAR/American College of Rheumatology points to consider for diagnosis, management and monitoring of the interleukin-1 mediated autoinflammatory diseases: cryopyrin-associated periodic syndromes, tumour necrosis factor receptor-associated periodic syndrome, mevalonate kinase deficiency, and deficiency of the interleukin-1 receptor antagonist – Annals of Rheumatic Diseases

 

M-A: Reproducibility of food challenge to cow’s milk.

15 Jun, 2022 | 10:42h | UTC

Reproducibility of food challenge to cow’s milk: a systematic review with individual participant data meta-analysis – Journal of Allergy and Clinical Immunology

 

Position Paper: Diagnostic therapeutic care pathway for pediatric food allergies and intolerances.

14 Jun, 2022 | 11:05h | UTC

Diagnostic therapeutic care pathway for pediatric food allergies and intolerances in Italy: a joint position paper by the Italian Society for Pediatric Gastroenterology Hepatology and Nutrition (SIGENP) and the Italian Society for Pediatric Allergy and Immunology (SIAIP) – Italian Journal of Pediatrics

 

Host-directed immunotherapy of viral and bacterial infections: past, present and future.

13 Jun, 2022 | 07:41h | UTC

Host-directed immunotherapy of viral and bacterial infections: past, present and future – Nature Reviews Immunology (if the link is paywalled, try this one in PMC)

 

Commentary on Twitter

 

Another study suggests the Omicron variant is associated with a reduced risk of Multisystem Inflammatory Syndrome in Children compared to previous SARS-CoV-2 variants.

10 Jun, 2022 | 12:38h | UTC

Risk and Phenotype of Multisystem Inflammatory Syndrome in Vaccinated and Unvaccinated Danish Children Before and During the Omicron Wave – JAMA Pediatrics

Related study: Severity and Incidence of Multisystem Inflammatory Syndrome in Children During 3 SARS-CoV-2 Pandemic Waves in Israel – JAMA AND Commentary: Kids’ COVID syndrome—MIS-C—less severe in Omicron – CIDRAP

 

Commentary on Twitter

 

Drug-related hypersensitivity reactions leading to emergency department: original data and systematic review.

10 Jun, 2022 | 10:46h | UTC

Drug-Related Hypersensitivity Reactions Leading to Emergency Department: Original Data and Systematic Review – Journal of Clinical Medicine

 

M-A: Oral Janus kinase inhibitors in the treatment of atopic dermatitis.

3 Jun, 2022 | 10:49h | UTC

Oral Janus kinase inhibitors in the treatment of atopic dermatitis: A systematic review and meta-analysis – Skin Health and Disease

Commentary: Systematic Review Suggests Oral JAK Inhibitors Effective in AD – HCP Live

 

Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.